Keeping Current CME podcast

Hormone Receptor-Positive, HER2-Negative Early Breast Cancer: The Adjuvant Clinical Trial Populations Explained

0:00
27:29
Rewind 15 seconds
Fast Forward 15 seconds

How do the eligibility criteria for the monarchE and NATALEE clinical trials compare?

Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1002403?ecd=bdc_podcast_libsyn_mscpedu

More episodes from "Keeping Current CME"